These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5267716)

  • 21. [Synthesis and alpha-adrenolytic activities of 2-(1,4-benzodioxan-2-yl- methyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives].
    Glusa E; Grüner H; Hagen A; Lohmann D; Foken H
    Pharmazie; 1990 Jun; 45(6):408-10. PubMed ID: 1976262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of antiglioma activity of biaryl 1,2,3,4-tetrahydroisoquinoline derivatives and conformationally flexible analogues.
    Mohler ML; Kang GS; Hong SS; Patil R; Kirichenko OV; Li W; Rakov IM; Geisert EE; Miller DD
    J Med Chem; 2006 Sep; 49(19):5845-8. PubMed ID: 16970409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [On the reaction of carbinolamines with diazoalkanes].
    Göber B; Pfeifer S; Hanus V; Engelhardt G
    Arch Pharm Ber Dtsch Pharm Ges; 1968 Oct; 301(10):763-75. PubMed ID: 5250533
    [No Abstract]   [Full Text] [Related]  

  • 24. 3,4-Dihydroisocarbostyril and 1,2,3,4-tetrahydroisoquinoline derivatives of ephedrine.
    Trepanier DL; Sunder S
    J Med Chem; 1973 Apr; 16(4):342-7. PubMed ID: 4716178
    [No Abstract]   [Full Text] [Related]  

  • 25. Synthesis and pharmacological investigations of 1,2,3,4-tetrahydroisoquinoline derivatives.
    Brzezinska E; Venter D; Glinka R
    Pharmazie; 1996 Jun; 51(6):397-9. PubMed ID: 8767849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Conversion of tetrahydroisoquinoline carbinoles with chloroformic acid ethyl ester].
    Wiegrebe W
    Arch Pharm Ber Dtsch Pharm Ges; 1968 Sep; 301(9):672-9. PubMed ID: 5251286
    [No Abstract]   [Full Text] [Related]  

  • 27. [N-substitution products of 4,4-dialkyl-homophthalimides. 14. N-alpha-hologenalkyl-carbonic acid amid].
    Böhme H; Meyer G
    Arch Pharm Ber Dtsch Pharm Ges; 1970 Jun; 303(6):514-8. PubMed ID: 5271599
    [No Abstract]   [Full Text] [Related]  

  • 28. [Synthesis of 4,4-diphenyl-3-oxy-6-sulfamyl-1,2,3,4-tetrahydroisoquinoline].
    Chernikh VP
    Farm Zh; 1978; (3):86-7. PubMed ID: 680116
    [No Abstract]   [Full Text] [Related]  

  • 29. Synthesis of saframycins. II. Preparations and reactions of N-methyl-2,5-piperazinediones.
    Kubo A; Saito N; Yamato H; Yamauchi R; Hiruma K; Inoue S
    Chem Pharm Bull (Tokyo); 1988 Jul; 36(7):2607-14. PubMed ID: 3240482
    [No Abstract]   [Full Text] [Related]  

  • 30. [DEHYDRATION OF TERTIARY AMINES WITH HG(II)-EDTA. 8. ON THE CONFIGURATION OF 1-BENZYL-N-TERT-BUTYL-1,2,3,4-TETRAHYDROISOQUINOLINE AND LAUDANOSINE].
    KNABE J; GRUND G
    Arch Pharm Ber Dtsch Pharm Ges; 1963 Dec; 296():854-8. PubMed ID: 14208666
    [No Abstract]   [Full Text] [Related]  

  • 31. 1,2,3,4-tetrahydroisoquinoline derivatives; lipophilicity evaluation vs. 5-HT1A receptor affinity.
    Bojarski AJ; Mokrosz MJ
    Pharmazie; 1999 Nov; 54(11):828-30. PubMed ID: 10603608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enantioselective double manipulation of tetrahydroisoquinolines with terminal alkynes and aldehydes under copper(I) catalysis.
    Lin W; Cao T; Fan W; Han Y; Kuang J; Luo H; Miao B; Tang X; Yu Q; Yuan W; Zhang J; Zhu C; Ma S
    Angew Chem Int Ed Engl; 2014 Jan; 53(1):277-81. PubMed ID: 24375740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Conversion of 1,2-dihydro-2-methyl-papaverinol in diluted acetic acid].
    Wiegrebe W; Roesel E
    Electromyography; 1969; 9(1):310-8. PubMed ID: 5355616
    [No Abstract]   [Full Text] [Related]  

  • 34. Synthesis of carbon-11 and fluorine-18 labeled N-acetyl-1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives as new potential PET AMPA receptor ligands.
    Gao M; Kong D; Clearfield A; Zheng QH
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2229-33. PubMed ID: 16455250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and synthesis of tetrahydroisoquinoline derivatives as potential multidrug resistance reversal agents in cancer.
    Li Y; Zhang HB; Huang WL; Li YM
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3652-5. PubMed ID: 18502125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tetrahydroisoquinoline derivatives containing a benzenesulfonamide moiety as potent, selective human beta3 adrenergic receptor agonists.
    Parmee ER; Brockunier LL; He J; Singh SB; Candelore MR; Cascieri MA; Deng L; Liu Y; Tota L; Wyvratt MJ; Fisher MH; Weber AE
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2283-6. PubMed ID: 11055339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and central nervous system actions of thyrotropin-releasing hormone analogs containing a 1-oxo-1,2,3,4-tetrahydroisoquinoline moiety.
    Maeda H; Suzuki M; Sugano H; Yamamura M; Ishida R
    Chem Pharm Bull (Tokyo); 1988 Jan; 36(1):190-201. PubMed ID: 3132333
    [No Abstract]   [Full Text] [Related]  

  • 38. Synthesis of the 1-phenethyltetrahydroisoquinoline alkaloids (+)-dysoxyline, (+)-colchiethanamine, and (+)-colchiethine.
    Reddy RJ; Kawai N; Uenishi J
    J Org Chem; 2012 Dec; 77(24):11101-8. PubMed ID: 23176065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Synthesis of D,L-N-(2-quinuclidinoyl)-1,2,3,4-tetrahydroiso-quinoline and D,L-N-(2-quinuclidinylmethyl)-1,2,3,4-tetrahydroisoquinoline].
    Biniecki S; Bulaciński A
    Acta Pol Pharm; 1974; 31(2):147-50. PubMed ID: 4840663
    [No Abstract]   [Full Text] [Related]  

  • 40. Synthesis of novel tetrahydroisoquinoline bronchodilators.
    Dalence-Guzmán MF; Toftered J; Oltner VT; Wensbo D; Johansson MH
    Bioorg Med Chem Lett; 2010 Sep; 20(17):4999-5003. PubMed ID: 20678935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.